{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:42:31Z","timestamp":1791686551374,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.biomaterials.2021.120825","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T23:51:57Z","timestamp":1618530717000},"page":"120825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Randomized peptide assemblies for enhancing immune responses to nanomaterials"],"prefix":"10.1016","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9707-0157","authenticated-orcid":false,"given":"Nicole L.","family":"Votaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Curvino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0570-2493","authenticated-orcid":false,"given":"Yaoying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea N.","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison T.","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel H.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2021.120825_bib1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.2147\/DDDT.S67861","article-title":"Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach","volume":"8","author":"Oany","year":"2014","journal-title":"Dddt"},{"key":"10.1016\/j.biomaterials.2021.120825_bib2","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.vaccine.2009.02.011","article-title":"A universal epitope-based influenza vaccine and its efficacy against H5N1","volume":"27","author":"Adar","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2021.120825_bib3","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1016\/j.vaccine.2009.09.060","article-title":"A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults","volume":"27","author":"Jin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2021.120825_bib4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"Elliott","year":"2008","journal-title":"Jvi"},{"key":"10.1016\/j.biomaterials.2021.120825_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10989-017-9667-4","article-title":"The immunogenicity and immunoprotection of VBP3 multi-epitope vaccine targeting angiogenesis and tumor inhibition in lung cancer- bearing mice","volume":"25","author":"Zhang","year":"2019","journal-title":"Int. J. Pept. Res. Therapeut."},{"key":"10.1016\/j.biomaterials.2021.120825_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jmgm.2017.06.004","article-title":"Identification of B and T cell epitope based peptide vaccine from IGF-1 receptor in breast cancer","volume":"75","author":"Mahdavi","year":"2017","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.biomaterials.2021.120825_bib7","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1128\/IAI.00566-12","article-title":"Construction and evaluation of a novel recombinant T cell epitope-based vaccine against coccidioidomycosis","volume":"80","author":"Hurtgen","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.biomaterials.2021.120825_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.vaccine.2012.10.091","article-title":"Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice","volume":"31","author":"Li","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2021.120825_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ebiom.2016.08.022","article-title":"Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy","volume":"11","author":"Zieglmayer","year":"2016","journal-title":"Ebiom"},{"key":"10.1016\/j.biomaterials.2021.120825_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/CVI.00066-11","article-title":"Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice","volume":"18","author":"Xu","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41591-018-0042-6","article-title":"Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1","volume":"24","author":"Xu","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2021.120825_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fonc.2018.00481","article-title":"Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models","volume":"8","author":"Grandi","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.09.031","article-title":"Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers","volume":"149","author":"Mora-Solano","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2021.120825_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01855","article-title":"Multifactorial design of a supramolecular peptide anti-IL-17 vaccine toward the treatment of psoriasis","volume":"11","author":"Shores","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1126\/science.aad9272","article-title":"Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells","volume":"352","author":"Sadtler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2021.120825_bib16","first-page":"1","article-title":"Interleukin-36y-producing macrophages drive il-17-mediated fibrosis","volume":"4","author":"Sommerfeld","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2021.120825_bib18","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.4049\/jimmunol.178.11.6814","article-title":"Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses","volume":"178","author":"Moutaftsi","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2021.120825_bib20","doi-asserted-by":"crossref","first-page":"119490","DOI":"10.1016\/j.biomaterials.2019.119490","article-title":"In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence","volume":"224","author":"Han","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2021.120825_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/CVI.00714-14","article-title":"Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice","volume":"22","author":"Grenfell","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib22","doi-asserted-by":"crossref","DOI":"10.1021\/acsbiomaterials.7b00488","article-title":"Single dose of protein vaccine with peptide nanofibers as adjuvants elicits long-lasting antibody titer","volume":"4","author":"Yang","year":"2018","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biomaterials.2021.120825_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/eji.1830010406","article-title":"Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide","volume":"1","author":"Teitelbaum","year":"1971","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.nurt.2007.08.002","article-title":"Mechanism of action of glatiramer acetate in treatment of multiple sclerosis","volume":"4","author":"Weber","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biomaterials.2021.120825_bib25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1191\/1352458503ms963oa","article-title":"Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy","volume":"9","author":"Teitelbaum","year":"2003","journal-title":"Mult. Scler."},{"key":"10.1016\/j.biomaterials.2021.120825_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00415-008-1005-5","article-title":"Glatiramer acetate","volume":"255","author":"Blanchette","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib27","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.4049\/jimmunol.170.9.4483","article-title":"Glatiramer acetate (Copolymer-1, Copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells","volume":"170","author":"Vieira","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1172\/JCI8970","article-title":"Glatiramer acetate (Copaxone\u00ae) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis","volume":"105","author":"Duda","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biomaterials.2021.120825_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2010.04.022","article-title":"Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing\u2013remitting or chronic EAE","volume":"225","author":"Aharoni","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.autrev.2012.09.005","article-title":"The mechanism of action of glatiramer acetate in multiple sclerosis and beyond","volume":"12","author":"Aharoni","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biomaterials.2021.120825_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.14.1.1","article-title":"Altered peptide ligand\u2013 induced partial T cell activation: molecular mechanisms and role in T cell biology","volume":"14","author":"Sloan-Lancaster","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1124\/jpet.106.103192","article-title":"Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease","volume":"318","author":"Aharoni","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.biomaterials.2021.120825_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.expneurol.2016.08.012","article-title":"Expression of brain-derived neurotrophic factor in astrocytes - beneficial effects of glatiramer acetate in the R6\/2 and YAC128 mouse models of Huntington's disease","volume":"285","author":"Reick","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib34","doi-asserted-by":"crossref","first-page":"11784","DOI":"10.1073\/pnas.0604681103","article-title":"Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1","volume":"103","author":"Butovsky","year":"2006","journal-title":"Pnas"},{"key":"10.1016\/j.biomaterials.2021.120825_bib35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/02713680802484637","article-title":"Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration","volume":"33","author":"Landa","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.biomaterials.2021.120825_bib36","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1016\/j.vaccine.2016.09.044","article-title":"Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus","volume":"34","author":"Friedrich","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2021.120825_bib37","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1021\/ja211725s","article-title":"A totally synthetic, self-assembling, adjuvant-free MUC1 glycopeptide vaccine for cancer therapy","volume":"134","author":"Huang","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2021.120825_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1021\/acsbiomaterials.6b00422","article-title":"Modular peptide amphiphile micelles improving an antibody- mediated immune response to group A Streptococcus","volume":"3","author":"Barrett","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biomaterials.2021.120825_bib39","doi-asserted-by":"crossref","DOI":"10.1021\/acsbiomaterials.7b00561","article-title":"A supramolecular vaccine platform based on \u03b1\u2010helical peptide nanofibers","volume":"3","author":"Wu","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biomaterials.2021.120825_bib40","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.1016\/j.biomaterials.2013.07.063","article-title":"The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation","volume":"34","author":"Chen","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2021.120825_bib41","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/adhm.201400137","article-title":"Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputs","volume":"3","author":"Pompano","year":"2014","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.biomaterials.2021.120825_bib42","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/jbm.a.35767","article-title":"Peptide biomaterials raising adaptive immune responses in wound healing contexts","volume":"104","author":"Vigneswaran","year":"2016","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.biomaterials.2021.120825_bib43","article-title":"Co-assembling peptides as defined matrices for endothelial cells, Biomaterials","volume":"30","author":"Jung","year":"2009"},{"key":"10.1016\/j.biomaterials.2021.120825_bib44","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1073\/pnas.0912124107","article-title":"A self-assembling peptide acting as an immune adjuvant","volume":"107","author":"Rudra","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biomaterials.2021.120825_bib45","doi-asserted-by":"crossref","first-page":"9274","DOI":"10.1021\/acsnano.6b03409","article-title":"Switching the immunogenicity of peptide assemblies using surface properties","volume":"10","author":"Wen","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2021.120825_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-8977-7-22","article-title":"Nanomaterial cytotoxicity is composition, size, and cell type dependent","volume":"7","author":"Sohaebuddin","year":"2010","journal-title":"Part. Fibre Toxicol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-3024.1994.tb00306.x","article-title":"The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni","volume":"16","author":"Mountford","year":"1994","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib48","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1021\/bm200763y","article-title":"Directed intermixing in multicomponent self-assembling biomaterials","volume":"12","author":"Gasiorowski","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2021.120825_bib49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2019.04.019","article-title":"MPL nano-liposomal vaccine containing P5 HER2\/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer","volume":"303","author":"Zamani","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2021.120825_bib50","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4049\/jimmunol.164.3.1625","article-title":"Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses","volume":"164","author":"Alexander","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib51","first-page":"121","article-title":"Dendritic cells expressing a combined PADRE\/MUC4-Derived polyepitope DNA vaccine induce multiple cytotoxic T-cell responses","volume":"23","author":"Wei","year":"2008","journal-title":"Canc. Biother. Rad."},{"key":"10.1016\/j.biomaterials.2021.120825_bib52","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Hengartner","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2021.120825_bib53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1389-0344(01)00101-0","article-title":"Recent developments in adjuvants for vaccines against infectious diseases","volume":"18","author":"OHagan","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.biomaterials.2021.120825_bib54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"15","key":"10.1016\/j.biomaterials.2021.120825_bib55","first-page":"142","article-title":"The IL-4 and IL-5 genes are closely linked and are part of a cytokine gene cluster on mouse chromosome","volume":"11","author":"Lee","year":"1989"},{"key":"10.1016\/j.biomaterials.2021.120825_bib56","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.4049\/jimmunol.131.5.2196","article-title":"Studies on the immunogenicity and tolerogenicity of T-independent antigens","volume":"131","author":"Dintzis","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib57","doi-asserted-by":"crossref","first-page":"9477","DOI":"10.1073\/pnas.95.16.9477","article-title":"T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles","volume":"95","author":"Fehr","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.biomaterials.2021.120825_bib58","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.cgh.2014.07.029","article-title":"Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab","volume":"13","author":"Yanai","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib59","first-page":"1460","article-title":"Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up","volume":"305","author":"Bartelds","year":"2011","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib60","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/265739a0","article-title":"Antibody-enhanced dengue virus infection in primate leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2021.120825_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"Jvi"},{"key":"10.1016\/j.biomaterials.2021.120825_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/nm1226","article-title":"Peptide-based therapeutic vaccines for allergic and autoimmune diseases","volume":"11","author":"Larch\u00e9","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2021.120825_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/826191","article-title":"Design of peptide immunotherapies for MHC class-II-associated autoimmune disorders","volume":"2013","author":"Fridkis-Hareli","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.biomaterials.2021.120825_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7243\/2054-989X-1-3","article-title":"Glatiramer acetate and therapeutic peptide vaccines for multiple sclerosis","volume":"1","author":"Conner","year":"2014","journal-title":"J. Autoimmun. Cell Responses"},{"key":"10.1016\/j.biomaterials.2021.120825_bib65","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4049\/jimmunol.1300312","article-title":"Orchestration of CD4 T cell epitope preferences after multipeptide immunization","volume":"191","author":"Tung","year":"2013","journal-title":"J. Immunol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221001812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221001812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:59:23Z","timestamp":1758905963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961221001812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":65,"alternative-id":["S0142961221001812"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120825","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized peptide assemblies for enhancing immune responses to nanomaterials","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120825"}}